680 related articles for article (PubMed ID: 19525956)
21. Cerebral vasculopathy is a common feature in Aicardi-Goutieres syndrome associated with SAMHD1 mutations.
du Moulin M; Nürnberg P; Crow YJ; Rutsch F
Proc Natl Acad Sci U S A; 2011 Jun; 108(26):E232; author reply E233. PubMed ID: 21633013
[No Abstract] [Full Text] [Related]
22. Atypical Aicardi-Goutieres syndrome: is the WRN locus a modifier?
Lessel D; Saha B; Hisama F; Kaymakamzade B; Nurlu G; Gursoy-Özdemir Y; Thiele H; Nürnberg P; Martin GM; Kubisch C; Oshima J
Am J Med Genet A; 2014 Oct; 164A(10):2510-3. PubMed ID: 24989684
[TBL] [Abstract][Full Text] [Related]
23. SAMHD1 host restriction factor: a link with innate immune sensing of retrovirus infection.
Sze A; Olagnier D; Lin R; van Grevenynghe J; Hiscott J
J Mol Biol; 2013 Dec; 425(24):4981-94. PubMed ID: 24161438
[TBL] [Abstract][Full Text] [Related]
24. Aicardi-Goutières syndrome.
Crow YJ
Handb Clin Neurol; 2013; 113():1629-35. PubMed ID: 23622384
[TBL] [Abstract][Full Text] [Related]
25. Impaired dNTPase activity of SAMHD1 by phosphomimetic mutation of Thr-592.
Tang C; Ji X; Wu L; Xiong Y
J Biol Chem; 2015 Oct; 290(44):26352-9. PubMed ID: 26294762
[TBL] [Abstract][Full Text] [Related]
26. SAMHD1: Recurring roles in cell cycle, viral restriction, cancer, and innate immunity.
Mauney CH; Hollis T
Autoimmunity; 2018 May; 51(3):96-110. PubMed ID: 29583030
[TBL] [Abstract][Full Text] [Related]
27. Modulation of LINE-1 and Alu/SVA retrotransposition by Aicardi-Goutières syndrome-related SAMHD1.
Zhao K; Du J; Han X; Goodier JL; Li P; Zhou X; Wei W; Evans SL; Li L; Zhang W; Cheung LE; Wang G; Kazazian HH; Yu XF
Cell Rep; 2013 Sep; 4(6):1108-15. PubMed ID: 24035396
[TBL] [Abstract][Full Text] [Related]
28. Multiple Autoimmune Disorders in Aicardi-Goutières Syndrome.
Samanta D; Ramakrishnaiah R; Crary SE; Sukumaran S; Burrow TA
Pediatr Neurol; 2019 Jul; 96():37-39. PubMed ID: 30898416
[TBL] [Abstract][Full Text] [Related]
29. SAMHD1-deficient CD14+ cells from individuals with Aicardi-Goutières syndrome are highly susceptible to HIV-1 infection.
Berger A; Sommer AF; Zwarg J; Hamdorf M; Welzel K; Esly N; Panitz S; Reuter A; Ramos I; Jatiani A; Mulder LC; Fernandez-Sesma A; Rutsch F; Simon V; König R; Flory E
PLoS Pathog; 2011 Dec; 7(12):e1002425. PubMed ID: 22174685
[TBL] [Abstract][Full Text] [Related]
30. Aicardi-Goutieres syndrome gene and HIV-1 restriction factor SAMHD1 is a dGTP-regulated deoxynucleotide triphosphohydrolase.
Powell RD; Holland PJ; Hollis T; Perrino FW
J Biol Chem; 2011 Dec; 286(51):43596-43600. PubMed ID: 22069334
[TBL] [Abstract][Full Text] [Related]
31. SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damage.
Clifford R; Louis T; Robbe P; Ackroyd S; Burns A; Timbs AT; Wright Colopy G; Dreau H; Sigaux F; Judde JG; Rotger M; Telenti A; Lin YL; Pasero P; Maelfait J; Titsias M; Cohen DR; Henderson SJ; Ross MT; Bentley D; Hillmen P; Pettitt A; Rehwinkel J; Knight SJ; Taylor JC; Crow YJ; Benkirane M; Schuh A
Blood; 2014 Feb; 123(7):1021-31. PubMed ID: 24335234
[TBL] [Abstract][Full Text] [Related]
32. SAMHD1 restricts HIV-1 replication and regulates interferon production in mouse myeloid cells.
Zhang R; Bloch N; Nguyen LA; Kim B; Landau NR
PLoS One; 2014; 9(2):e89558. PubMed ID: 24586870
[TBL] [Abstract][Full Text] [Related]
33. Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein.
Hrecka K; Hao C; Gierszewska M; Swanson SK; Kesik-Brodacka M; Srivastava S; Florens L; Washburn MP; Skowronski J
Nature; 2011 Jun; 474(7353):658-61. PubMed ID: 21720370
[TBL] [Abstract][Full Text] [Related]
34. SAMHD1-deficient fibroblasts from Aicardi-Goutières Syndrome patients can escape senescence and accumulate mutations.
Franzolin E; Coletta S; Ferraro P; Pontarin G; D'Aronco G; Stevanoni M; Palumbo E; Cagnin S; Bertoldi L; Feltrin E; Valle G; Russo A; Bianchi V; Rampazzo C
FASEB J; 2020 Jan; 34(1):631-647. PubMed ID: 31914608
[TBL] [Abstract][Full Text] [Related]
35. A SAMHD1 mutation associated with Aicardi-Goutières syndrome uncouples the ability of SAMHD1 to restrict HIV-1 from its ability to downmodulate type I interferon in humans.
White TE; Brandariz-Nuñez A; Martinez-Lopez A; Knowlton C; Lenzi G; Kim B; Ivanov D; Diaz-Griffero F
Hum Mutat; 2017 Jun; 38(6):658-668. PubMed ID: 28229507
[TBL] [Abstract][Full Text] [Related]
36. CyclinA2-Cyclin-dependent Kinase Regulates SAMHD1 Protein Phosphohydrolase Domain.
Yan J; Hao C; DeLucia M; Swanson S; Florens L; Washburn MP; Ahn J; Skowronski J
J Biol Chem; 2015 May; 290(21):13279-92. PubMed ID: 25847232
[TBL] [Abstract][Full Text] [Related]
37. SAMHD1 controls innate immunity by regulating condensation of immunogenic self RNA.
Maharana S; Kretschmer S; Hunger S; Yan X; Kuster D; Traikov S; Zillinger T; Gentzel M; Elangovan S; Dasgupta P; Chappidi N; Lucas N; Maser KI; Maatz H; Rapp A; Marchand V; Chang YT; Motorin Y; Hubner N; Hartmann G; Hyman AA; Alberti S; Lee-Kirsch MA
Mol Cell; 2022 Oct; 82(19):3712-3728.e10. PubMed ID: 36150385
[TBL] [Abstract][Full Text] [Related]
38. SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx.
Laguette N; Sobhian B; Casartelli N; Ringeard M; Chable-Bessia C; Ségéral E; Yatim A; Emiliani S; Schwartz O; Benkirane M
Nature; 2011 May; 474(7353):654-7. PubMed ID: 21613998
[TBL] [Abstract][Full Text] [Related]
39. The eukaryotic elongation factor eEF1A1 interacts with SAMHD1.
Morrissey C; Schwefel D; Ennis-Adeniran V; Taylor IA; Crow YJ; Webb M
Biochem J; 2015 Feb; 466(1):69-76. PubMed ID: 25423367
[TBL] [Abstract][Full Text] [Related]
40. Characterization of samhd1 morphant zebrafish recapitulates features of the human type I interferonopathy Aicardi-Goutières syndrome.
Kasher PR; Jenkinson EM; Briolat V; Gent D; Morrissey C; Zeef LA; Rice GI; Levraud JP; Crow YJ
J Immunol; 2015 Mar; 194(6):2819-25. PubMed ID: 25672750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
